Publications

Reply.

DOCKRELL, HM; Black, GF; Weir, RE; FINE, PE M;

2002

The Journal of infectious diseases, (2002).186 3 10.1086/341655.

HIV-1/AIDS and the control of other infectious diseases in Africa.

CORBETT, EL; Steketee, RW; Ter Kuile, FO; Latif, AS; Kamali, A; HAYES, RJ;

2002

Lancet, (2002).359 9324 10.1016/S0140-6736(02)09095-5.

Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo.

Lienhardt, C; Azzurri, A; Amedei, A; FIELDING, K; Sillah, J; Sow, OY; Bah, B; Benagiano, M; Diallo, A; Manetti, R; Manneh, K; Gustafson, P; Bennett, S; D'Elios, MM; McAdam, K; Del Prete, G;

2002

European journal of immunology, (2002).32 63.0.CO;2-6" target="_blank"> 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6 .

Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population.

Hussain, R; Kaleem, A; Shahid, F; Dojki, M; Jamil, B; Mehmood, H; Dawood, G; DOCKRELL, HM;

2002

Journal of immunological methods, (2002).264 1-2 10.1016/s0022-1759(02)00092-3.

Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis.

Gordhan, BG; Smith, DA; ALDERTON, H; McAdam, RA; BANCROFT, GJ; Mizrahi, V;

2002

Infection and immunity, (2002).70 6 10.1128/IAI.70.6.3080-3084.2002.

HIV-1 and tuberculosis infection.

Sonnenberg, P; GODFREY-FAUSSETT, P; GLYNN, JR; Shearer, S; Murray, J;

2002

Lancet, (2002).359 9317 10.1016/s0140-6736(02)08497-0.

Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.

CORBETT, EL; Churchyard, GJ; Charalambos, S; Samb, B; Moloi, V; CLAYTON, TC; GRANT, AD; Murray, J; HAYES, RJ; De Cock, KM;

2002

Clinical infectious diseases, (2002).34 9 10.1086/339540.

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.

Black, GF; Weir, RE; FLOYD, S; Bliss, L; Warndorff, DK; CRAMPIN, AC; Ngwira, B; Sichali, L; Nazareth, B; Blackwell, JM; BRANSON, K; Chaguluka, SD; Donovan, L; Jarman, E; KING, E; FINE, PE M; DOCKRELL, HM;

2002

Lancet, (2002).359 9315 10.1016/S0140-6736(02)08353-8.

Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda.

Lugada, ES; Watera, C; Nakiyingi, J; ELLIOTT, A; Brink, A; Nanyunja, M; FRENCH, N; Antivelink, L; Gilks, C; WHITWORTH, J;

2002

The international journal of tuberculosis and lung disease, (2002).6 4

Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients.

Smith, SM; Klein, MR; Malin, AS; Sillah, J; McAdam, KP W J; DOCKRELL, HM;

2002

Tuberculosis (Edinburgh, Scotland), (2002).82 1 10.1054/tube.2001.0317.